Organon & Co. (OGN)
Organon & Co. - Organon Reports Results for the First Quarter Ended March 31, 2026
Organon & Co. - Organon Reports Results for the First Quarter Ended March 31, 2026
SIGA - SIGA to Host Business Update Call on May 7, 2026, Following Release of First-Quarter 2026 Financial Results
Aptose Biosciences Announces Update on Anticipated Timing of Closing of the Plan of Arrangement with Hanmi Pharmaceutical
Bragg Powers Super Technologies’ Entry into Greece with RGS and Aggregation Offering
Distribution Solutions Group Announces 2026 First Quarter Results
DT Midstream Reports Strong First Quarter 2026 Results
Verastem Oncology Launches HCP and Patient Reimagine Campaign to Increase Awareness of AVMAPKI® FAKZYNJA® CO-PACK for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer
TG Therapeutics to Host Conference Call on First Quarter 2026 Financial Results and Business Update
Ealixir Launches Beta of RepuTrust, an AI-Powered Digital Identity Platform, Granting Early Access to Our Select Users
Vireo Growth to Acquire FLUENT in All-Stock Transaction